121 related articles for article (PubMed ID: 29450647)
1. RNA versus protein toxicity in C9orf72 ALS/FTLD.
Arzberger T; Schludi MH; Lehmer C; Schmid B; Edbauer D
Acta Neuropathol; 2018 Mar; 135(3):475-479. PubMed ID: 29450647
[No Abstract] [Full Text] [Related]
2. C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
Xiao S; MacNair L; McLean J; McGoldrick P; McKeever P; Soleimani S; Keith J; Zinman L; Rogaeva E; Robertson J
Brain Res; 2016 Sep; 1647():43-49. PubMed ID: 27134035
[TBL] [Abstract][Full Text] [Related]
3. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
[TBL] [Abstract][Full Text] [Related]
4. Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity.
Gittings LM; Boeynaems S; Lightwood D; Clargo A; Topia S; Nakayama L; Troakes C; Mann DMA; Gitler AD; Lashley T; Isaacs AM
Acta Neuropathol; 2020 Feb; 139(2):407-410. PubMed ID: 31832771
[No Abstract] [Full Text] [Related]
5. Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Vatovec S; Kovanda A; Rogelj B
Neurobiol Aging; 2014 Oct; 35(10):2421.e1-2421.e12. PubMed ID: 24836899
[TBL] [Abstract][Full Text] [Related]
6. Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients.
Prudencio M; Gonzales PK; Cook CN; Gendron TF; Daughrity LM; Song Y; Ebbert MTW; van Blitterswijk M; Zhang YJ; Jansen-West K; Baker MC; DeTure M; Rademakers R; Boylan KB; Dickson DW; Petrucelli L; Link CD
Hum Mol Genet; 2017 Sep; 26(17):3421-3431. PubMed ID: 28637276
[TBL] [Abstract][Full Text] [Related]
7. The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum.
Van Langenhove T; van der Zee J; Van Broeckhoven C
Ann Med; 2012 Dec; 44(8):817-28. PubMed ID: 22420316
[TBL] [Abstract][Full Text] [Related]
8. Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum.
Cruts M; Gijselinck I; Van Langenhove T; van der Zee J; Van Broeckhoven C
Trends Neurosci; 2013 Aug; 36(8):450-9. PubMed ID: 23746459
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of melanoma in C9ORF72 repeat expansion carriers: A case-control study.
Tábuas-Pereira M; Almendra L; Almeida MR; Durães J; Pinho A; Matos A; Negrão L; Geraldo A; Santana I
Muscle Nerve; 2019 Mar; 59(3):362-365. PubMed ID: 30447080
[TBL] [Abstract][Full Text] [Related]
10. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients.
Xi Z; Zhang M; Bruni AC; Maletta RG; Colao R; Fratta P; Polke JM; Sweeney MG; Mudanohwo E; Nacmias B; Sorbi S; Tartaglia MC; Rainero I; Rubino E; Pinessi L; Galimberti D; Surace EI; McGoldrick P; McKeever P; Moreno D; Sato C; Liang Y; Keith J; Zinman L; Robertson J; Rogaeva E
Acta Neuropathol; 2015 May; 129(5):715-27. PubMed ID: 25716178
[TBL] [Abstract][Full Text] [Related]
11. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis.
Irwin DJ; McMillan CT; Brettschneider J; Libon DJ; Powers J; Rascovsky K; Toledo JB; Boller A; Bekisz J; Chandrasekaran K; Wood EM; Shaw LM; Woo JH; Cook PA; Wolk DA; Arnold SE; Van Deerlin VM; McCluskey LF; Elman L; Lee VM; Trojanowski JQ; Grossman M
J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):163-9. PubMed ID: 23117491
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients.
Xi Z; Rainero I; Rubino E; Pinessi L; Bruni AC; Maletta RG; Nacmias B; Sorbi S; Galimberti D; Surace EI; Zheng Y; Moreno D; Sato C; Liang Y; Zhou Y; Robertson J; Zinman L; Tartaglia MC; St George-Hyslop P; Rogaeva E
Hum Mol Genet; 2014 Nov; 23(21):5630-7. PubMed ID: 24908669
[TBL] [Abstract][Full Text] [Related]
13. Jump from pre-mutation to pathologic expansion in C9orf72.
Xi Z; van Blitterswijk M; Zhang M; McGoldrick P; McLean JR; Yunusova Y; Knock E; Moreno D; Sato C; McKeever PM; Schneider R; Keith J; Petrescu N; Fraser P; Tartaglia MC; Baker MC; Graff-Radford NR; Boylan KB; Dickson DW; Mackenzie IR; Rademakers R; Robertson J; Zinman L; Rogaeva E
Am J Hum Genet; 2015 Jun; 96(6):962-70. PubMed ID: 26004200
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers for Alzheimer's disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion.
Kämäläinen A; Herukka SK; Hartikainen P; Helisalmi S; Moilanen V; Knuuttila A; Jansson L; Tienari PJ; Remes AM
Dement Geriatr Cogn Disord; 2015; 39(5-6):287-93. PubMed ID: 25791939
[TBL] [Abstract][Full Text] [Related]
15. The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues.
Woollacott IO; Mead S
Acta Neuropathol; 2014 Mar; 127(3):319-32. PubMed ID: 24515836
[TBL] [Abstract][Full Text] [Related]
16. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
17. Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion.
Udine E; DeJesus-Hernandez M; Tian S; das Neves SP; Crook R; Finch NA; Baker MC; Pottier C; Graff-Radford NR; Boeve BF; Petersen RC; Knopman DS; Josephs KA; Oskarsson B; Da Mesquita S; Petrucelli L; Gendron TF; Dickson DW; Rademakers R; van Blitterswijk M
Acta Neuropathol; 2024 Apr; 147(1):73. PubMed ID: 38641715
[TBL] [Abstract][Full Text] [Related]
18. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.
Mori K; Weng SM; Arzberger T; May S; Rentzsch K; Kremmer E; Schmid B; Kretzschmar HA; Cruts M; Van Broeckhoven C; Haass C; Edbauer D
Science; 2013 Mar; 339(6125):1335-8. PubMed ID: 23393093
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of C9ORF72 Expansion in a Large Series of Patients with Idiopathic Normal-Pressure Hydrocephalus.
Korhonen VE; Remes AM; Helisalmi S; Rauramaa T; Sutela A; Vanninen R; Suhonen NM; Haapasalo A; Hiltunen M; Jääskeläinen JE; Soininen H; Koivisto AM; Leinonen V
Dement Geriatr Cogn Disord; 2019; 47(1-2):91-103. PubMed ID: 30861516
[TBL] [Abstract][Full Text] [Related]
20. Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration.
Ohki Y; Wenninger-Weinzierl A; Hruscha A; Asakawa K; Kawakami K; Haass C; Edbauer D; Schmid B
Mol Neurodegener; 2017 Jan; 12(1):6. PubMed ID: 28088213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
